Arcadia Biosciences Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Arcadia Biosciences Inc.
Ownership: Public
Status: Active
Sector (GICS): Energy
SIC code: 1311 — Crude Petroleum & Natural Gas
Jurisdiction of incorporation: Delaware
Headquarters city: Dallas
Headquarters state / province: Texas
Headquarters country: United States
Fiscal year end: December
Ticker symbol: RKDA
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001469443
EIN: 81-0571538

Board of directors

Follow this board

Albert D. Bolles · Director
Since 2023
Amy Yoder · Director
Since 2023
Deborah D. Carosella · Director
Since 2023
Gregory D. Waller · Director
Since 2023
Kevin Comcowich · Director
Since 2023
Lilian Shackelford Murray · Director
Since 2023

Director election results

Annual meeting of September 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Gregory D. Waller

78.2%

Board connections

2 of this board's directors also sit on 2 other boards.

Shared director Other board Same sector

Compass Minerals Intl Inc
via Amy Yoder
Nuwellis Inc.
via Gregory D. Waller

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Feb 3, 2025	Kawakami Mark Officer (Chief Financial Officer)	Open-market purchase	+700	$2.49	$1,743
Feb 3, 2025	Schaefer Thomas J. Officer (Chief Executive Officer)	Open-market purchase	+700	$2.49	$1,743
Aug 1, 2024	Kawakami Mark Officer (Chief Financial Officer)	Open-market purchase	+700	$2.06	$1,442
Aug 1, 2024	Schaefer Thomas J. Officer (Chief Executive Officer)	Open-market purchase	+700	$2.06	$1,442
Feb 1, 2024	Schaefer Thomas J. Officer (Chief Financial Officer)	Open-market purchase	+700	$2.06	$1,442
Aug 4, 2023	Schaefer Thomas J. Officer (Chief Financial Officer)	Open-market purchase	+649	$3.67	$2,382
May 30, 2023	Jacot Stanley Jr Officer (Chief Executive Officer)	Open-market purchase	+5,000	$4.31	$21,550
Feb 1, 2023	Schaefer Thomas J. Officer (Chief Financial Officer)	Open-market purchase	+700	$0.23	$161

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

APA Corporation Nasdaq: APA · Houston, United States Organization ARKO Petroleum Corp. Nasdaq: APC · Richmond, United States Organization Abundia Global Impact Group Inc. NYSE American: AGIG · Houston, United States Organization AleAnna Inc. Nasdaq: ANNA · Dallas, United States Organization

Questions about Arcadia Biosciences Inc.

How many directors are on Arcadia Biosciences Inc.'s board?

Arcadia Biosciences Inc.'s board has 6 directors: Albert D. Bolles, Amy Yoder, Deborah D. Carosella, Gregory D. Waller, Kevin Comcowich and Lilian Shackelford Murray.

How is Arcadia Biosciences Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="arcadia-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.